Continuing Education

CME Now Available for MEMC22

Thank you for attending the XI^th Mediterranean Emergency Medicine (MEMC22) in Malta. You can now claim your CME for MEMC22 and pre-congress courses.

Access the CME portal to submit speaker evaluations and print your AMA PRA Category 1 Credit(s)™ certificate(s) or a certificate of attendance. Please log in using your AAEM username and password. If you do not have an AAEM account, you may create one. 

DOs may convert AMA PRA Category 1 Credits™ to AOA Category 2 credits by following these steps.

Please contact Rebecca Sommer, CME and Education Manager with any questions.

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American Academy of Emergency Medicine (AAEM) and the Mediterranean Chapter Division of AAEM (MAEM). AAEM is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement

The American Academy of Emergency Medicine (AAEM) designates these live activities for the following maximum credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.     

• XIth  Mediterranean Emergency Medicine Congress – 27.75 AMA PRA Category 1 Credit(s)™
• Emergency Cardiology Conundrums – 6.75 AMA PRA Category 1 Credit(s)™
• ToX in a BoX – 6 AMA PRA Category 1 Credit(s)™
• Is there a Doctor on Board? – 3.75 AMA PRA Category 1 Credit(s)™

Disclosures of Financial Relationships

The American Academy of Emergency Medicine (AAEM) endorses the guidelines for continuing medical education programs as set forth in the Accreditation Council for Continuing Medical Education (ACCME). This activity has been planned and implemented in accordance with the Accreditation Criteria, the Standards for Integrity and Independence in Accredited Continuing Education, and Accreditation Policies. AAEM maintains control over the development of its educational programs and the selection of topics and presenters.

A full disclosure of relevant financial relationships is required of all faculty members and the presence of any such relationship will be reported to all program attendees. In accordance with these policies, AAEM would like to make the following information known to all course participants.

The following speakers have disclosed a financial relationship:

S. Eliza Dunn (Halcomb), MD FACMT
Bayer U.S. Crop Science, Employee, Salary

Gary M. Gaddis, MD PhD FAAEM FIFEM
Johnson and Johnson Company, Stock options

Nicholas B. Hurst, MD MS FAAEM FACEP
Rare Disease Therapeutics, Inc, Employee, Salary

Chadd K. Kraus, DO DrPH MPH FACEP
Cytovale, contracted research consulting fee

Christopher A. Lewandowski, MD FAAEM
Takeda Pharmaceutical Company, Consultant, Consulting fee

Richard M. Nowak, MD MBA FACEP FAAEM
Siemens Healthcare, Consultant, Consulting fee; Abbott Diagnostics, Consultant, Consulting fee; Beckman Coulter, Consultant, Consulting fee; Roche Diagnostics, Consultant, Consulting fee

Adam Singer, MD
Janssen, Speaking and teaching, Honoraria; Bristol Myers Squibb, Speaking and teaching, Honoraria; AstraZeneca, Speaking and teaching, Honoraria; Neomatrix, Consultant, Consulting fee

Timothy Wiegand, MD
McKesson, Consultant, Consulting fee

Leslie S. Zun, MD MBA FAAEM
Impel Neuropharma, Consultant, Consulting fee

Speakers with financial disclosures had their disclosures reviewed and mitigated. No other speakers have disclosed a financial relationship.

The following track chairs and planning committee members have disclosed a financial relationship:

Gary M. Gaddis, MD PhD FAAEM FIFEM
Johnson and Johnson Company, Ownership of common stock

Ziad N. Kazzi, MD FAAEM FACMT FAACT
Pfizer Inc., Research grant funding

Lisa A. Moreno, MD MS MSCR FAAEM FIFEM
Gilead, FOCUS Research Grant, Contracted research

Leslie S. Zun, MD MBA FAAEM
Impel Neuropharma, Consultant, Consulting fee

Track chairs and planning committee members who disclosed a financial relationship had their disclosures reviewed and mitigated. No other track chairs or planning committee members have disclosed a financial relationship.

No staff members have disclosed a financial relationship.

Commercial Support
Bayer provided monetary commercial support for this activity.